Lagler, H., Grabmeier-Pfistershammer, K., Touzeau-Römer, V., Tobudic, S., Ramharter, M., Wenisch, J., . . . Burgmann, H. (2012). Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Lagler, Heimo, et al. Immunogenicity and Tolerability After Two Doses of Non-adjuvanted, Whole-virion Pandemic Influenza A (H1N1) Vaccine in HIV-infected Individuals. Public Library of Science (PLoS), 2012.
Cita MLA (8a ed.)Lagler, Heimo, et al. Immunogenicity and Tolerability After Two Doses of Non-adjuvanted, Whole-virion Pandemic Influenza A (H1N1) Vaccine in HIV-infected Individuals. Public Library of Science (PLoS), 2012.